Several studies evaluated the presence of SARS-CoV-2 in the environment. Saliva and nasopharyngeal droplets can land on objects and surfaces, creating fomites.
KEYWORDS: SARS-CoV-2, biological fluids, droplets, environmental contamination, fomite, microbiota
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination occurs through droplets and biological fluids released in the surroundings from patients or asymptomatic carriers. Surfaces and objects contaminated by saliva or nose secretions represent a risk for indirect transmission of coronavirus disease 2019 (COVID-19). We assayed surfaces from hospital and living spaces to identify the presence of viral RNA and the spread of fomites in the environment. Anthropic contamination by droplets and biological fluids was monitored by detecting the microbiota signature using multiplex quantitative real-time PCR (qPCR) on selected species and massive sequencing on 16S amplicons. A total of 92 samples (flocked swabs) were collected from critical areas during the pandemic, including indoor (three hospitals and three public buildings) and outdoor surfaces exposed to anthropic contamination (handles and handrails, playgrounds). Traces of biological fluids were frequently detected in spaces open to the public and on objects that are touched with the hands (>80%). However, viral RNA was not detected in hospital wards or other indoor and outdoor surfaces either in the air system of a COVID hospital but only in the surroundings of an infected patient, in consistent association with droplet traces and fomites. Handled objects accumulated the highest level of multiple contaminations by saliva, nose secretions, and fecal traces, further supporting the priority role of handwashing in prevention. In conclusion, anthropic contamination by droplets and biological fluids is widespread in spaces open to the public and can be traced by qPCR. Monitoring fomites can support evaluation of indirect transmission risks for coronavirus or other flu-like viruses in the environment.
IMPORTANCE Several studies have evaluated the presence of SARS-CoV-2 in the environment. Saliva and nasopharyngeal droplets can land on objects and surfaces, creating fomites. A suitable indicator would allow the detection of droplets or biofluids carrying the virus. Therefore, we searched for viral RNA and droplets and fomites on at risk surfaces. We monitored by qPCR or next generation sequencing (NGS) droplets through their microbiota. Although the study was performed during the pandemic, SARS-CoV-2 was not significantly found on surfaces, with the only exception of environmental areas near infectious patients. Conversely, anthropic contamination was frequent, suggesting a role for biofluids as putative markers of indirect transmission and risk assessment. Moreover, all SARS-CoV-2-contaminated surfaces showed droplets’ microbiota. Fomite monitoring by qPCR may have an impact on public health strategies, supporting prevention of indirect transmission similarly to what is done for other communicable diseases (e.g., influenza and influenza-like infections).
INTRODUCTION
The ongoing pandemic of coronavirus disease 2019 (COVID-19) epidemiologically depends on person-to-person close contacts and inhalation of virus-laden liquid droplets (1–6). However, it is suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be indirectly transmitted through environmental contamination of objects and surfaces by biological fluids (e.g., saliva, nose secretion, urine, or fecal samples) (7–16). Respiratory droplets (aerodynamic diameter ranging between 6 and 10 μm) and droplet nuclei or aerosols (≤5 μm) can directly reach the mouth, nose, or eyes of a susceptible person but can also land on surfaces (17–20). Coronaviruses can survive on different matrices under different conditions, persisting from hours to days, especially in indoor environments (21–23).
Knowledge about environmental contamination is important during outbreaks and transition phases to enforce public health measures for symptomatic and asymptomatic individuals (22–24). Concerns about environmental contamination and the associated risk of indirect transmission can be raised in environments at highest risks (e.g., hospitals), where SARS-CoV-2 was detected, even when sanitation was accurately performed (8, 9, 13, 24–29).
The detection of fomites and biological fluids in the environment can be used as a potential marker of hygiene and of indirect SARS-CoV-2 transmission. On this basis, hospitals and public buildings were surveyed for the presence of SARS-CoV-2, droplets, fomites, and anthropic contaminations: traces of the microbiota signature of their own biofluids of origin were searched. A dedicated set of primers and probes was combined to detect different biological fluids based on multiplex reactions in quantitative real-time PCR (qPCR), following a strategy initially developed for forensic studies and hospital hygiene (30–34). A real-time PCR-based approach was adopted to test SARS-CoV-2 RNA (reverse transcriptase quantitative PCR [RT-qPCR]) and bacterial DNA from fomites by qPCR microbiota signature, amplifying genes from at least one representative bacterial component of the biological fluid (e.g., Streptococcus salivarius and Streptococcus mutans for saliva, Corynebacterium for nose secretions, Enterococcus faecalis and Bacteroides for fecal traces) (35–39). Findings were validated by next generation sequencing (NGS), which evaluated the microflora DNA (mfDNA) sampled with environmental swabs on indoor and outdoor surfaces (40–44). Although NGS is time-consuming and requires a bioinformatic analysis, it provides a larger view of the microbiota components, including the bacterial indicators selected for qPCR. qPCR and NGS can be used on the same samples to characterize the environmental microflora by cycle threshold (CT) analysis of selected marker genes or by read counts on 16S amplicon sequences, respectively (Fig. 1). High-throughput analysis of 16S rDNA by NGS can provide sequences of hundreds of bacterial species helping to define the whole microbiota, so that the anthropic contamination becomes a component of the whole microflora detectable on a surface. Both NGS and qPCR analyze DNA without providing information on the vitality of the biological agents. While NGS requires specific equipment and protocols, the qPCR approach uses the same instruments and procedures of the RT-qPCR.
The aim of this study was to assess the presence of SARS-CoV-2 and fomites in hospitals and public buildings in order to evaluate qPCR monitoring of fomites and biofluids as indicators of hygiene, as well as markers of SARS-CoV-2 transmission.
RESULTS AND DISCUSSION
Detection of fomites by qPCR is a feasible and effective approach.
Anthropic contamination by droplets and biofluids was detected on several environmental surfaces by qPCR (Table 1). Fomites were found in indoor and outdoor areas exposed to human crowding or frequently touched by hands. Floors and walls were less contaminated than handles or buttons. Droplet DNA traces were detected in the majority of the sampled surfaces, and almost 10% of sampled points displayed multiple contamination from different biological fluids. Correlation between selected bacterial species and biological fluids in droplets and fomites was confirmed (P value < 0.01) (Table 2), supporting the effectiveness of the approach. The combined action of different markers is synergic (Fig. 2), allowing a reliable identification of droplets and fomites. Indoor and outdoor samples showed the presence of traces from one or more human biofluids, although with different frequencies. qPCR can show not only the presence of biofluids and droplet traces but also the contamination level. Automated nucleic acid extraction and detection of anthropic contamination from environmental swabs could be implemented following the example adopted for the management of human swabs; therefore, detection of fomites by qPCR seems a feasible and promising approach even on a larger scale.
TABLE 1.
Code | Skin | Droplets |
Feces | Sample description | ||
---|---|---|---|---|---|---|
Sample source | Nasopharynx | Oropharynx | ||||
Controls (n = 4) | A_01 | − | +++ | − | − | Droplet biofluid |
A_02 | ++++ | +++++ | + | − | Droplet biofluid | |
A_03 | ++++ | +++++ | ++ | − | Droplet biofluid | |
A_04 | ++++ | ++++++ | + | − | Droplet biofluid | |
Outdoor (n = 6) | Z_01 | +++ | +++ | − | + | Handrail |
Z_02 | +/− | + | − | − | Bus stop bench | |
Z_03 | ++ | ++ | − | +/− | Shared e-scouter grip | |
Z_04 | − | + | − | − | External door handle | |
Z_05 | ++ | + | − | +/− | External door handle | |
Z_06 | ++ | + | − | − | Coffee dispenser | |
Indoor (n = 55) | YH1_01 | +++ | ++ | + | + | Right bed rail* |
YH1_02 | +++ | ++ | +/− | +/− | Bedside table | |
YH1_03 | ++ | +++ | ++++ | +++ | Door handle | |
YH1_04 | ++ | +++ | − | +/− | Floor | |
YH1_05 | ++ | ++++ | + | +++ | Call button* | |
YH1_06 | ++ | ++ | − | − | Table | |
YH1_07 | − | ++ | − | − | Chair | |
YH1_08 | − | +++ | − | − | Back of the bed | |
YH1_09 | − | ++ | − | − | Air inlet socket | |
YH1_10 | +++ | ++ | +++ | − | Wall behind the bed | |
YH1_11 | +++ | +++ | +++ | ++ | Left bed rail | |
YH1_12 | − | +++ | − | − | Stethoscope* | |
YH1_13 | − | +++ | − | − | Bottom of the bed | |
YH1_14 | + | ++++ | − | +/− | Wheelchair head | |
YH2_15 | ++++ | ++ | − | − | Pillow | |
YH2_16 | − | + | − | − | Chair | |
YH2_17 | − | + | − | − | Back of the bed | |
YH2_18 | − | +/− | − | +/− | Toilet board | |
YH2_19 | − | +/− | − | + | Sink faucet | |
YH2_20 | − | ++ | − | − | Floor | |
YH2_21 | + | +/− | − | − | Floor | |
YH2_22 | − | ++ | ++++ | − | Floor | |
YH2_23 | − | + | − | − | Door handle | |
YH2_24 | +++ | ++ | − | +/− | Back of the bed | |
YH2_25 | ++ | + | ++++ | − | Side of bed | |
YH2_26 | + | + | − | +++ | Side of bed | |
YH2_27 | − | − | − | − | Bedside table | |
YH2_28 | − | +/− | − | + | Bedside table | |
YH2_29 | − | ++ | − | − | Pillow | |
YH2_30 | − | + | − | − | Bed sheets | |
YH2_31 | + | ++ | − | − | Floor | |
YH2_32 | − | ++ | − | − | Floor | |
YH2_33 | − | + | − | − | Floor | |
YH3_34 | ++++++ | ++++ | − | − | Toilet | |
YH3_35 | − | ++ | − | − | Toilet | |
YH3_36 | +/− | − | − | − | Door handle | |
YC_37 | − | + | − | − | Pew and surface | |
YC_38 | − | + | − | − | Pew and surface | |
YC_39 | − | + | − | − | Pew and surface | |
YC_40 | ++ | ++++ | + | − | Pew and surface | |
YO_41 | − | − | − | + | Floor | |
YO_42 | − | − | +/− | +/− | Floor | |
YO_43 | − | − | − | + | Floor | |
YO_44 | − | − | − | + | Floor | |
YO_45 | − | − | − | − | Floor | |
YO_46 | − | − | − | + | Floor | |
YO_47 | − | − | − | +/− | Toilet wall tiles | |
YO_48 | − | − | − | + | Toilet wall tiles | |
YO_49 | − | − | − | + | Toilet wall tiles | |
YO_50 | − | − | − | +/− | Office phone | |
YO_51 | − | − | − | + | Computer keyboard | |
YO_52 | +/− | − | − | + | Computer keyboard | |
YO_53 | + | + | + | + | Elevator handle | |
YO_54 | +++ | +++ | + | +/− | Toilet door handle | |
YO_55 | ++ | ++ | − | − | Toilet flush button |
The cumulative output of indicators for each anthropic contamination is shown, including the description of each sample. For each biological fluid, at least two indicators were used: +++, positive with CT < 20; ++, positive with CT of 21 to 30; +, positive with CT of 31 to 35; +/−, low-confidence positive with CT of 36 to 38; −, negative CT >39; for E. coli, ++, positive with CT < 20; +, positive with CT of 21 to 29; +/−, low-confidence positive with CT of 30 to 35; −, negative with CT > 36. The sampling points where SARS-CoV-2 RNA was detected are indicated by an asterisk. Sample reading code: A, anthropic; Z, outdoor; Y, indoor (H, hospital; C, church; O, office and restaurant).
TABLE 2.
Origin | qPCR droplet markers |
|||
---|---|---|---|---|
Indicators | RC1 | RC2 | RC3 | |
Nasopharynx | Propionibacterium spp. | 0.93 | 0.05 | −0.01 |
Corynebacterium spp. | 0.66 | −0.03 | 0.39 | |
Oropharynx | Streptococcus mutans | 0.21 | 0.76 | 0.11 |
Streptococcus salivarius | 0.02 | 0.89 | −0.15 | |
Nostril-skin | Staphylococcus aureus | 0.06 | 0.30 | 0.80 |
Staphylococcus epidermidis | 0.13 | −0.07 | 0.88 |
Pattern matrix for principal-component analysis nasopharynx selected indicators (Propionibacterium spp., Corynebacterium spp.), oropharynx (Streptococcus mutans, Staphylococcus salivarius), of nostril-skin (Staphylococcus aureus, Staphylococcus epidermidis). The higher correlations for each component (RC) are shown in boldface type (P < 0.01). The table reported variable loading on the rotation matrix.
SARS-CoV-2 on surfaces in hospitals and public places is not widely disseminated, unless in proximity of an infected patient.
SARS-CoV-2 was not detected in the majority of the indoor and outdoor sampling points, including all 15 sampling points within the air system of a COVID-19 hospital. SARS-CoV-2 RNA was detected only in one room where an infected patient was hospitalized and only in those samples collected near the patient (one on the bed rail and one on the surface of the call button). Furthermore, the stethoscope used for the patient was also positive. The lower (<4%) frequency of positive samples in comparison with other studies (20 to 30%) can be explained by the epidemiology rather than to differences in the sampling strategy or to a lower sensitivity of the method (36); other studies were conducted during the epidemic peak, whereas our study was carried out after the lockdown, when reopening of activities was carefully performed and preventive measures were strictly enforced (7–16, 18, 45–47). Environmental spread of SARS-CoV-2 was not relevant, with the only exception of the surfaces near a hospitalized infected patient.
NGS confirms microbial signature by qPCR.
The microbial signature was confirmed by NGS, and all selected bacterial indicators were included within the microbiota identified by high-throughput sequencing and bioinformatic analysis. Both qPCR and NGS showed the prevalent contamination patterns (Fig. 3 and 4). DNA test can be easily performed within 1 day on any real-time apparatus, whereas NGS can be performed within 1 week, adapting the laboratory protocol to the high-throughput sequencer. Therefore, each selected indicator amplified by qPCR was found by NGS, but only as a subcomponent between others (about 200 to 1,000 species for each sample), including unknown species (∼5 to 10%). Mean values ranged from 0.24% (Bacteroides) to 5.78% (Corynebacterium). For example, Corynebacterium showed lower values (<1%) in environmental samples exposed to multiple sources of microbial pollutions, whereas the highest values (35 to 80%) were observed for environmental swabs contaminated by nasopharyngeal secretions. The correspondence between qPCR and NGS was reliable: two independent SARS-CoV-2-positive samples (YH1_01 and YH1_05) of a patient surroundings closely gathered, whereas the sample collected from the stethoscope (YH1_12) segregated at a different distance (Fig. 5). The anthropic contaminations on the right side of the bed (YH1_01) and on the call bottom (YH1_05) showed a similar biodiversity pattern (Shannon index, 2.602 and 2.893, respectively), suggesting a potential contamination performed by the patient’s right hand. Conversely, sample YH1_12 displayed microbiota traces associated with the nasopharyngeal secretions and with a different biodiversity pattern (Shannon index, 2.161), suggesting a possible contact of the stethoscope. NGS found environmental bacteria of the microbiota of human biological fluids.
Droplets and biofluids are frequently detected in fomites, representing a risk for indirect transmission of SARS-CoV-2.
qPCR analysis of fomites allowed the identification of resident or ectopic microflora. NGS showed fomites on several surfaces exposed to anthropic contamination and inhabiting microorganisms or those from other environmental sources. Samples collected from indoor and outdoor surfaces independently grouped if compared with samples containing human biofluids (Fig. 6). Within the outdoor group, those with a higher anthropic contamination overlapped with indoor samples, far from those where the environmental component was overwhelming. Interestingly, only an outdoor sample segregated outside—and between—both groups: the external handle of the entrance of a public building (Z_04), characterized by multiple contaminations of anthropic origin overlaying the outside microflora. Other indoor samples grouped together. These findings highlight the usefulness of microbiota-related data for tracing fomites. However, if fomites can be a risk, the transmission rate is low and depends on the presence of the specific viable pathogens (48). The environmental survival of SARS-CoV-2 depends on indoor and outdoor factors, including sanitation, time of release of the biological fluid, humidity, temperature, air circulation, and sunlight (49–53). Therefore, detection of fomites should be considered an indicator of transmission risk. Monitoring droplets and biofluids by qPCR can help prevent SARS-CoV-2 transmission suggesting continuous environmental surveillance and sanitization procedures.
Critical issues and limits of the study.
The study aim was the assessment of a novel qPCR-based approach and not a detailed risk assessment. Therefore, the comparison between sampling points or buildings cannot be performed, not only because of the small sample size but also for the random collection from areas with a different incidence of infection. Several Italian regions were recruited to avoid a geographical bias; however, the epidemiological burden can affect the inference of the results. Therefore, we suggested a strategy to assess contamination, which could point out a risk of indirect transmission of SARS-CoV-2. Interestingly, SARS-CoV-2-positive samples were collected only in Emilia-Romagna, Italy, where the incidence of infection was high during the epidemic peak (47). Nevertheless, our findings seem to confirm the key role played by hands. qPCR is faster than NGS (3 to 5 h versus 5 to 10 days) but not rapid compared with other molecular methods (33, 54). Tracing droplets and biological fluids by qPCR or NGS has a high specificity (18, 19, 55, 56). qPCR and NGS primers and probes for some bacterial genes were selected because of their feasibility and effectiveness; however, comparisons of sequences, indicators, or reaction conditions were not performed. Whole-genome sequencing would have been more informative, as well as the study of additional S16 rDNA regions (V1 and V2 together with V3, V4, V6, and V7). However, they are expensive (e.g., materials and reagents, bioinformatic analysis) and inappropriate for public health purposes on a larger scale. Finally, we used arbitrary thresholds to quantify droplets contamination based on CT values, recommending the highest sensitivity for droplet detection. A lower threshold could increase the specificity or can be helpful for monitoring transmission routes or sanitation.
Conclusion.
Environmental monitoring of fomites can be performed by qPCR, with the identification of anthropic contaminations by detecting their microbiota component.
Droplets and biological fluids were observed in indoor environments exposed to humans and on surfaces frequently touched by hands. SARS-CoV-2 was not detectable, with the only exception of environmental areas near to a patient. Our results indirectly highlight the importance of handwashing and environmental sanitation, as well as the role of health education.
In addition to the environmental detection of SARS-CoV-2, the detection of fomites by qPCR may provide an indicator for monitoring indirect transmission of SARS-CoV-2 and other biological agents transmitted through droplets.
MATERIALS AND METHODS
Sampling and experimental design.
Surfaces at risk for the presence of biological fluids and the transmission of COVID-19 were sampled from different settings, both in indoor and outdoor areas. Environmental samples (n = 94) were collected during May-June, after the epidemic peak that occurred in Italy in March 2020. We sampled indoor surfaces from three COVID reference hospitals in three Italian regions (Parma, Emilia-Romagna; Sassari, Sardinia; Rome, Lazio), other buildings open to the public (one office, one fast food restaurant, and one church), surfaces in outdoor areas, and used handkerchiefs with nasopharyngeal secretions. All samples were tested for SARS-CoV-2 RNA, whereas anthropic contamination was assessed by searching for biological fluids from nose, mouth, and gut through detection of their microbiota traces by qPCR and/or NGS (Table 3). As reported in Table 1, the sample reading code used letters and numbers as follows: A, anthropic contamination; Z, outdoor surface; Y, indoor surface; H, hospital; C, church; O, other sampling points in office or restaurant surfaces. All A, Z, and Y samples were collected within the Rome district, while YH1, YH2, and YH3 correspond to the hospitals in Rome, Parma, and Sassari, respectively.
TABLE 3.
Classification |
No. of samples in data set (n = 94) | Description | Nucleic acid testing |
|||
---|---|---|---|---|---|---|
Surface source | Sample | |||||
SARS-CoV-2 (RT-qPCR) | Biofluid (qPCR) | Microbiota (NGS) | ||||
Indoor | Hospital | 49 | Floor (n = 7) | + | + | + |
Bedside table (n = 3) | + | + | + | |||
Door handle (n = 3) | + | + | + | |||
Call button (n = 1) | + | + | + | |||
Table (n = 1) | + | + | + | |||
Chair (n = 2) | + | + | + | |||
Back of the bed (n = 3) | + | + | + | |||
Side of bed (n = 4) | + | + | + | |||
Bottom of the bed (n = 1) | + | + | + | |||
Wall behind the bed head (n = 1) | + | + | + | |||
Bed sheets (n = 1) | + | + | + | |||
Pillow (n = 2) | + | + | + | |||
Stethoscope (n = 1) | + | + | + | |||
Wheelchair head (n = 1) | + | + | + | |||
Toilet board (n = 1) | + | + | + | |||
Toilet flush button (n = 1) | + | + | + | |||
Sink faucet (n = 1) | + | + | + | |||
Air circulation system (15) | + | − | − | |||
Public building | 25 | Door handle (n = 2) | ± | + | + | |
Toilet (n = 2) | + | + | + | |||
Pews (n = 4) | − | + | + | |||
Floor (n = 6) | ± | + | + | |||
Toilet wall tiles (n = 3) | ± | + | + | |||
Office phone (n = 1) | + | + | + | |||
Computer keyboard (n = 2) | + | + | + | |||
Air circulation system (n = 5) | − | + | + | |||
Outdoor | 16 | Handrail (n = 1) | + | + | + | |
Grip shared e-scouter (n = 1) | + | + | + | |||
Bus stop bench (n = 1) | + | + | + | |||
Coffee dispenser button (n = 1) | + | + | + | |||
External door handle (n = 2) | ± | + | + | |||
Playground (n = 10) | − | ± | + | |||
Human | 4 | Droplet biofluid (n = 4) | ± | + | + |
Indoor surfaces were sampled from different hospitals (n = 3), buildings of public use (one office, one fast food restaurant, and one church), outdoor areas (n = 16), nose-oropharyngeal secretions (n = 4) and tested for the presence of SARS-CoV-2 by quantitative reverse transcription real-time PCR (RT-qPCR) and for anthropic contamination by testing the presence of microbiota traces of biological fluids (nose, saliva, Feces), by quantitative real-time PCR (qPCR) and/or next generation sequencing (NGS). For each type of test, analysis was performed in all (+), none (−), or some (±) of the collected samples.
Sampling collection.
Surface sampling was carried out after their regular use and prolonged exposure to human presence (>4 h), following standard protocols. FLOGSwabs and CITOSSWAB were used and immediately soaked into a buffer solution of UTM-RM transport medium in a volume of 400 μl (Copan Diagnostics Inc., Murrieta, CA, USA). The nasopharyngeal secretions were collected on handkerchiefs with swabs (4N6FLOQSwabs; Copan Diagnostics Inc., Murrieta, CA, USA). All specimens were refrigerated at 4°C before being tested.
SARS-CoV-2 detection.
All samples in UTM were heat inactivated at 56°C for 5 min to reduce the risk of accidental transmission of SARS-CoV-2 to laboratory personnel. Nucleic acids were purified and extracted using the eMag automated nucleic acid sample extraction system (bioMérieux, Marcy l’Etoile, France). Briefly, total nucleic acids were extracted from UTM using an input sample volume of 200 μl into 2,000 μl of easyMag lysis buffer using B protocol to a final eluted volume of purified nucleic acids of 50 μl. TaqPath one-step reverse transcriptase quantitative PCR (RT-qPCR) master mix (Life Technologies, Frederick, MD) and the 2019-nCoV CDC EUA kit (Integrated DNA Technologies, Coralville, IA) were used for target detection (57). Molecular detection of SARS-CoV-2 RNA was carried out by RT-qPCR, using primers and probes related to the E and N genes with a detection limit of 5.2 copies of RNA/reaction (55). Samples were analyzed in Sassari and Parma with the Allplex 2019-nCoV assay (Seegene, Seoul, South Korea) and in Rome with the Detection kit for 2019 Novel Coronavirus (2019-nCoV) RNA (PCR-Fluorescence Probing) (Daan Gene Co., Ltd., of Sun Yat-University, Guangzhou, Guandong, China) for the confirmation of the results. The Allplex 2019-nCoV assay was designed for amplifying three viral targets: the E gene (subgenus Sarbecovirus), the N, and the RdRP genes (58). The Detection kit for 2019 Novel Coronavirus (2019-nCoV) RNA (PCR-Fluorescence Probing) was designed for simultaneous identification of N and Orf1ab genes. Afterward, 5-μl portions of eluted RNA samples in a total volume of 25 μl were amplified on Bio-Rad CFX96 real-time system. In each round of extraction and amplification, positive and negative control samples (supplied by the manufacturer) were included. Laboratory controls included serial 10-fold dilutions of an internal positive sample that were analyzed in triplicate (R2 = 0.99), further supporting the reproducibility and capability to detect SARS-CoV-2 RNA up to the limit of detection of the assay. The interpretation criteria were the following: (i) positive signals detected in E, N, and RdRP ORF1ab and N genes with cycle threshold (CT) values of ≤40 were considered positive for SARS-CoV-2 RNA; (ii) positive signals in only one gene (E, N, or RdRP/Orf1ab) with CT values of ≤40 were considered inconclusive; and (iii) no fluorescent signals or over the 40th CT in RdRP/ORF1ab and N genes were considered not specific and reported as negative for SARS-CoV-2 RNA. The declared limit of detection (LoD) is 500 RNA copies/ml, following the manufacturer’s information.
DNA extraction.
An aliquot of COPAN UTM-RM transport medium (about 300 μl) was centrifuged at 16,000 × g for 10 min, and the pellet was manually disaggregated with a pestle after adding glass beads (Sigma-Aldrich, St. Louis, MO) and lysed in 200 μl lysozyme solution, RNase A treated, and proteinase K digested according to the GenElute Bacterial Genomic DNA kit (Sigma-Aldrich, St. Louis, MO, USA). Finally, DNA elution was performed in 60 μl elution solution (10 mM Tris-hydrochloride and 0.5 mM ethylene diamine tetraacetic acid [pH 9.0]). For pharyngeal biofluids and fomites samples, each swab was inserted into the semipermeable NAO Baskets and broken inside at the breakpoint. Approximately 200 μl lysozyme solution (20 mg/ml lysozyme, 20 mM tris[hydroxymethyl]aminomethanehydrochloride at pH 8, 2 mM ethylenediaminetetraacetic acid, and 1.2% Triton X-100; Sigma-Aldrich, St. Louis, USA) were added into the NAO Baskets and incubated at 37°C for 30 min. Then, 20 μl proteinase K and 400 μl buffer AL were added, and the sample was centrifuged at 10,000 × g for 1 min, allowing the elution of the digestion solution. After incubation at 56°C for 10 min and addition of 400 μl ethanol, the washing step and DNA purification were performed in accordance with the manufacturer’s instructions. DNA elution was completed in 60 μl elution solution [10 mM tris(hydroxymethyl)aminomethane-hydrochloride and 0.5 mM ethylenediaminetetraacetic acid at pH 9.0], as previously described (32, 33).
Analysis of mfDNA by multiplex real-time PCR and data interpretation.
Amplifications were combined in four multiplex reactions: mix skin, for the identification of Staphylococcus aureus and Staphylococcus epidermidis; mix nasopharynx for Propionibacterium spp. and Corynebacterium spp.; mix oralpharinx for Streptococcus salivarius and Streptococcus mutans; mix feces for Enterococcus spp. and Bacteroides vulgatus (probes were labeled FAM/VIC/HEX, with the BHQ-1 quencher). Primers for different bacterial indicators and optimized reaction conditions were already established as previously described (4, 30, 59, 60, 61). Briefly, amplifications were performed in a volume of 25 μl, of which 12.5 μl JumpStart Taq ReadyMix for Quantitative PCR (Sigma-Aldrich, St. Louis, MO), containing 900 nM forward and reverse primers, and 250 nM each probe. For each mix, samples were tested in triplicate. The amplifications were performed using Bio-RadCFX96 (Bio-Rad, Hercules, CA) programmed for 10 min at 95°C and 40 cycles with 1 cycle consisting of 15 s at 95°C and 1 min at 60°C. For each sample, 11 μl template reaction was amplified. The PCR output was expressed as cycle threshold (CT). Positive samples were those where ≥1 positive indicator (CT ≤ 35) was found in at least two mixes. Conversely, a microbial indicator was considered negative when it was over the CT ≥ 39 threshold. In particular, for each biological fluid, at least two bacterial markers were used, and for each indicator, the following criteria were used: +++, positive, CT < 20; ++, positive, CT of 21–30; +, positive with CT of 31 to 35; +/−, low-confidence positive with CT of 36 to 38; −, negative with CT > 39. Due to the use of recombinant and not native polymerase or Escherichia coli the criteria were modified as follows: ++, positive with CT < 20; +, positive with CT of 21 to 29; +/−, low-confidence positive with CT of 30 to 35; −, negative with CT >36; the criteria were modified in order to avoid false-positive data due to the detection of E. coli DNA in the recombinant enzyme used for amplification (62).
16S rDNA amplicon sequencing analysis.
Libraries for NGS were prepared according to the 16S Metagenomic Sequencing Library Preparation Guide (part 15044223 rev A; Illumina, San Diego, CA, USA). The PCR amplicons were obtained using Ba27F and Ba338R primers containing overhang adapters, as previously described (33, 63). Tagged PCR products were generated using primer pairs with unique barcodes through two-step PCR. In this strategy, target primers containing overhang adapters were used in the first PCR to amplify the target gene, that product was then used in the second PCR using primers-containing barcodes. Each amplification reaction had a total volume of 25 μl, containing 12.5 μl of KAPA HiFi Hot Start Ready Mix (Roche, Pleasanton, CA, USA), 5 μl of each primer (1 μM), and 2 μl of template DNA. Reactions were carried out on a Techne TC-PLUS thermocycler (VWR International, LLC, Radnor, PA, USA). Following amplification, 5 μl of PCR product from each reaction was used for agarose gel (1%) electrophoresis to confirm amplification. The final concentration of cleaned DNA amplicon was determined using the Qubit PicoGreen dsDNA BR assay kit (Invitrogen, Grand Island, NY, USA) and validated on a Bioanalyzer DNA 1000 chip (Agilent, Santa Clara, CA, USA). Libraries were prepared using the MiSeq reagent kit preparation guide (Illumina, San Diego, CA, USA). Raw sequence data were processed using an in-house pipeline that was built on the Galaxy platform and incorporated various software tools to evaluate the quality of the raw sequence data (FASTA/Q Information tools, Mothur). All data sets were rigorously screened to remove low-quality reads (short reads > 200 nucleotides [nt], zero-ambiguous sequences). Demultiplexing was performed to remove PhiX sequences and sort sequences; moreover, to minimize sequencing errors and ensure sequence quality, the reads were trimmed based on the sequence quality score using Btrim (an average quality score of 30 from the ends, and remove reads that are less than 200 bp after end trimming) (64). OTUs (operational taxonomic units) were clustered at a 97% similarity level, final OTUs were generated based on the clustering results, and taxonomic annotations of individual OTUs were based on representative sequences using RDP’s 16S Classifier 2.5. Observed OTUs were defined as observed species. A level of 97% sequence identity is often chosen as representative of a species and 95% for a genus (65). The sequence reads were analyzed also in the cloud environment BaseSpace through the 16S Metagenomics app (version 1.0.1; Illumina): the taxonomic database used was the Illumina-curated version (May 2013 release of the Greengenes Consortium Database) (65).
Statistical analysis.
Relative abundances of community members were determined with rarefied data and summarized at each taxonomic level. The proportion of the microbiome at each taxonomic rank, such as phylum, order, class, family, and genus, was determined using the RDP classifier and the Greengenes Database. Alpha and beta diversity were calculated using EstimateS software at a level of 97% sequence similarity. Regarding alpha diversity, the Shannon index and equitability index at the species level were computed (66, 67). Principal-component analysis (PCA) was performed using the METAGENassist platform and R (version 3.1.3, www.R-project.org) with packages “ggplot2,” “ape,” “psych,” and “vegan” (68). Multivariate analysis, the PCA, and partial least square-discriminant analysis (PLS-DA) were performed in order to investigate the dissimilarity between groups. Feature selection was performed using PLS-DA and 10-fold cross validation to tune algorithm parameters and to check model validity. Dendrogram and clustering analysis were based on the Euclidean distance and Ward’s method.
Data availability.
The raw sequencing data were deposited in the NCBI Sequence Read Archive under accession number PRJNA685983. The analyses were carried out using an online Galaxy server available at http://huttenhower.sph.harvard.edu/galaxy.
ACKNOWLEDGMENTS
We thank Elena Scaramucci, Tiziana Zilli, and Pietro Robert for supporting bibliography search and management; Alessandro Stabile for ensuring laboratory safety and acceptance of reagents during summertime; the Copan Italia S.p.A. Brescia Italy for providing eNAT and UTM collection kits.
This study was partially supported by University of Foro Italico Projects (CDR2TER012013, CDR2Ter012015-10301, CDR2BANDO2017SVR) assigned to V.R.S.
REFERENCES
- 1.World Health Organization. 9 July 2020. Transmission of SARS-CoV-2: implications for infection prevention precautions. Scientific Brief. World Health Organization, Geneva, Switzerland: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions. [Google Scholar]
- 2.Stadnytskyi V, Bax CE, Bax A, Anfinrud P. 2020. The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. Proc Natl Acad Sci U S A 117:11875–11877. doi: 10.1073/pnas.2006874117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Somsen GA, van Rijn C, Kooij S, Bem RA, Bonn D. 2020. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir Med 8:658–659. doi: 10.1016/S2213-2600(20)30245-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Liu Q, Liu Q, Meng H, Lv H, Liu Y, Liu J, Wang H, He L, Qin J, Wang Y, Dai Y, Otto M, Li M. 2020. Staphylococcus epidermidis contributes to healthy maturation of the nasal microbiome by stimulating antimicrobial peptide production. Cell Host Microbe 27:68–78. doi: 10.1016/j.chom.2019.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.National Center for Immunization and Respiratory Diseases (NCIRD). 2020. How COVID-19 spreads. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA. https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html. Last accessed 10 August 2020.
- 6.Asadi S, Wexler AS, Cappa CD, Barreda S, Bouvier NM, Ristenpart WD. 2020. Effect of voicing and articulation manner on aerosol particle emission during human speech. PLoS One 15:e0227699. doi: 10.1371/journal.pone.0227699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. 2020. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 382:1564–1567. doi: 10.1056/NEJMc2004973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Chia PY, Coleman KK, Tan YK, Ong SWX, Gum M, Lau SK, Lim XF, Lim AS, Sutjipto S, Lee PH, Son TT, Young BE, Milton DK, Gray GC, Schuster S, Barkham T, De PP, Vasoo S, Chan M, Ang BSP, Tan BH, Leo YS, Ng OT, Wong MSY, Marimuthu K, Singapore 2019 Novel Coronavirus Outbreak Research Team. 2020. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat Comm 11:2800. doi: 10.1038/s41467-020-16670-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Guo ZD, Wang ZY, Zhang SF, Li X, Li L, Li C, Cui Y, Fu RB, Dong YZ, Chi XY, Zhang MY, Liu K, Cao C, Liu B, Zhang K, Gao YW, Lu B, Chen W. 2020. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis 26:1583–1591. doi: 10.3201/eid2607.200885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Cheng VCC, Wong SC, Chan VWM, So SYC, Chen JHK, Yip CCY, Chan KH, Chu H, Chung TWH, Sridhar S, To KKW, Chan JFW, Hung IFN, Ho PL, Yuen KY. 2020. Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol 41:1258–1265. doi: 10.1017/ice.2020.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. 2020. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 323:1610–1612. doi: 10.1001/jama.2020.3227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lv J, Yang J, Xue J, Zhu P, Liu L, Li S. 2020. Detection of SARS-CoV-2 RNA residue on object surfaces in nucleic acid testing laboratory using droplet digital PCR. Sci Total Environ 742:140370. doi: 10.1016/j.scitotenv.2020.140370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Razzini K, Castrica M, Menchetti L, Maggi L, Negroni L, Orfeo NV, Pizzoccheri A, Stocco M, Muttini S, Balzaretti CM. 2020. SARS-CoV-2 RNA detection in the air and on surfaces in the COVID-19 ward of a hospital in Milan, Italy. Sci Total Environ 742:140540. doi: 10.1016/j.scitotenv.2020.140540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, Yang Y, Liu B, Wang W, Wei C, Yang J, Ye G, Cheng Z. 2020. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol 92:833–840. doi: 10.1002/jmv.25825. [DOI] [PubMed] [Google Scholar]
- 15.Foladori P, Cutrupi F, Segata N, Manara S, Pinto F, Malpei F, Bruni L, La Rosa G. 2020. SARS-CoV-2 from faeces to wastewater treatment: what do we know? A review. Sci Total Environ 743:140444. doi: 10.1016/j.scitotenv.2020.140444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Li HY, Fan YZ, Jiang L, Wang HB. 2020. Aerosol and environmental surface monitoring for SARS-Cov-2 RNA in a designated hospital for severe COVID-19 patients. Epidemiol Infect 148:e154. doi: 10.1017/S0950268820001570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.World Health Organization. 2014. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. WHO guidelines. World Health Organization, Geneva, Switzerland: https://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf;jsessionid=41AA684FB64571CE8D8A453C4F2B2096?sequence=1. [PubMed] [Google Scholar]
- 18.Wei L, Lin J, Duan X, Huang W, Lu X, Zhou J, Zong Z. 2020. Asymptomatic COVID-19 patients can contaminate their surroundings: an environment sampling study. mSphere 5:e00442-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. 2016. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect 92:235–250. doi: 10.1016/j.jhin.2015.08.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Al Huraimel K, Alhosani M, Kunhabdulla S, Stietiya MH. 2020. SARS-CoV-2 in the environment: modes of transmission, early detection and potential role of pollutions. Sci Total Environ 744:140946. doi: 10.1016/j.scitotenv.2020.140946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Eslami H, Jalili M. 2020. The role of environmental factors to transmission of SARS-CoV-2 (COVID-19). AMB Express 10:92. doi: 10.1186/s13568-020-01028-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kampf G, Todt D, Pfaender S, Steinmann E. 2020. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 104:246–251. doi: 10.1016/j.jhin.2020.01.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hung IF, Cheng VC, Li X, Tam AR, Hung DL, Chiu KH, Yip CC, Cai JP, Ho DT, Wong SC, Leung SS, Chu MY, Tang MO, Chen JH, Poon RW, Fung AY, Zhang RR, Yan EY, Chen LL, Choi CY, Leung KH, Chung TW, Lam SH, Lam TP, Chan JF, Chan KH, Wu TC, Ho PL, Chan JW, Lau CS, To KK, Yuen KY. 2020. SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series. Lancet Infect Dis 20:1051–1060. doi: 10.1016/S1473-3099(20)30364-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wu S, Wang Y, Jin X, Tian J, Liu J, Mao Y. 2020. Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019. Am J Infect Control 48:910–914. doi: 10.1016/j.ajic.2020.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ding Z, Qian H, Xu B, Huang Y, Miao T, Yen H-L, Xiao S, Cui L, Wu X, Shao W, Song Y, Sha L, Zhou L, Xu Y, Zhu B, Li Y. 2021. Toilets dominate environmental detection of severe acute respiratory syndrome coronavirus 2 in a hospital. Sci Total Environ 753:141710. doi: 10.1016/j.scitotenv.2020.141710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Feng B, Xu K, Gu S, Zheng S, Zou Q, Xu Y, Yu L, Lou F, Yu F, Jin T, Li Y, Sheng J, Yen H-L, Zhong Z, Wei J, Chen Y. 2021. Multi-route transmission potential of SARS-CoV-2 in healthcare facilities. J Hazard Mater 402:123771. doi: 10.1016/j.jhazmat.2020.123771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Huang Y, Ding Z, Chen Q, Wu L, Guo L, Zhao C, Sha L, Sun H. 2021. Environmental virus detection associated with asymptomatic SARS-CoV-2-infected individuals with positive anal swabs. Sci Total Environ 753:142289. doi: 10.1016/j.scitotenv.2020.142289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wan B, Zhang X, Luo D, Zhang T, Chen X, Yao Y, Zhao X, Lei L, Liu C, Zhao W, Zhou L, Ge Y, Mao H, Liu S, Chen J, Cheng X, Zhao J, Sui G. 2021. On-site analysis of COVID-19 on the surfaces in wards. Sci Total Environ 753:141758. doi: 10.1016/j.scitotenv.2020.141758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wang J, Feng H, Zhang S, Ni Z, Ni L, Chen Y, Zhuo L, Zhong Z, Qu T. 2020. SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital. Int J Infect Dis 94:103–106. doi: 10.1016/j.ijid.2020.04.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Giampaoli S, Berti A, Valeriani F, Gianfranceschi G, Piccolella A, Buggiotti L, Rapone C, Valentini A, Ripani L, Romano Spica V. 2012. Molecular identification of vaginal fluid by microbial signature. Forensic Sci Int Genet 6:559–564. doi: 10.1016/j.fsigen.2012.01.005. [DOI] [PubMed] [Google Scholar]
- 31.Giampaoli S, Alessandrini F, Berti A, Ripani L, Choi A, Crab R, De Vittori E, Egyed B, Haas C, Lee HY, Korabecná M, Noel F, Podini D, Tagliabracci A, Valentini A, Romano Spica V. 2014. Forensic interlaboratory evaluation of the ForFLUID kit for vaginal fluids identification. J Forensic Leg Med 21:60–63. doi: 10.1016/j.jflm.2013.10.016. [DOI] [PubMed] [Google Scholar]
- 32.Valeriani F, Protano C, Gianfranceschi G, Cozza P, Campanella V, Liguori G, Vitali M, Divizia M, Romano Spica V. 2016. Infection control in healthcare settings: perspectives for mfDNA analysis in monitoring sanitation procedures. BMC Infect Dis 16:394. doi: 10.1186/s12879-016-1714-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Valeriani F, Agodi A, Casini B, Cristina ML, D’Errico MM, Gianfranceschi G, Liguori G, Liguori R, Mucci N, Mura I, Pasquarella C, Piana A, Sotgiu G, Privitera G, Protano C, Quattrocchi A, Ripabelli G, Rossini A, Spagnolo AM, Tamburro M, Tardivo S, Veronesi L, Vitali M, Romano Spica V, GISIO Working Group of the Italian Society of Hygiene, Preventive Medicine, and Public Health. 2018. Potential testing of reprocessing procedures by real-time polymerase chain reaction: a multicenter study of colonoscopy devices. Am J Infect Control 46:159–164. doi: 10.1016/j.ajic.2017.08.008. [DOI] [PubMed] [Google Scholar]
- 34.Yao T, Han X, Guan T, Wang Z, Zhang S, Liu C, Liu C, Chen L. 2020. Effect of indoor environmental exposure on seminal microbiota and its application in body fluid identification. Forensic Sci Int 314:110417. doi: 10.1016/j.forsciint.2020.110417. [DOI] [PubMed] [Google Scholar]
- 35.Esberg A, Haworth S, Kuja-Halkola R, Magnusson P, Johansson I. 2020. Heritability of oral microbiota and immune responses to oral bacteria. Microorganisms 8:1126. doi: 10.3390/microorganisms8081126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, Sun L, Duan Y, Cai J, Westerdahl D, Liu X, Xu K, Ho KF, Kan H, Fu Q, Lan K. 2020. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature 582:557–560. doi: 10.1038/s41586-020-2271-3. [DOI] [PubMed] [Google Scholar]
- 37.Charles DD, Fisher JR, Hoskinson SM, Medina-Colorado AA, Shen YC, Chaaban MR, Widen SG, Eaves-Pyles TD, Maxwell CA, Miller AL, Popov VL, Pyles RB. 2019. Development of a novel ex vivo nasal epithelial cell model supporting colonization with human nasal microbiota. Front Cell Infect Microbiol 9:165. doi: 10.3389/fcimb.2019.00165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Proctor L, Lo Tempio J, Marquitz A, Daschner P, Xi D, Flores R, Brown L, Ranallo R, Maruvada P, Regan K, Lunsford RD, Reddy M, Caler L. 2019. A review of 10 years of human microbiome research activities at the US National Institutes of Health, fiscal years 2007–2016. Microbiome 7:31. doi: 10.1186/s40168-019-0620-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lloyd-Price J, Abu-Ali G, Huttenhower C. 2016. The healthy human microbiome. Genome Med 8:51. doi: 10.1186/s13073-016-0307-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Slatko BE, Gardner AF, Ausubel FM. 2018. Overview of next-generation sequencing technologies. Curr Protoc Mol Biol 122:e59. doi: 10.1002/cpmb.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Valeriani F, Crognale S, Protano C, Gianfranceschi G, Orsini M, Vitali M, Romano Spica V. 2018. Metagenomic analysis of bacterial community in a travertine depositing hot spring. New Microbiol 41:126–135. [PubMed] [Google Scholar]
- 42.Valeriani F, Protano C, Gianfranceschi G, Leoni E, Galasso V, Mucci N, Romano Spica V. 2018. Microflora Thermarum Atlas project: biodiversity in thermal spring waters and natural SPA pools. Water Supply 18:1472–1483. doi: 10.2166/ws.2017.215. [DOI] [Google Scholar]
- 43.Valeriani F, Margarucci LM, Gianfranceschi G, Ciccarelli A, Tajani F, Mucci N, Ripani M, Romano Spica V. 2019. Artificial-turf surfaces for sport and recreational activities: microbiota analysis and 16S sequencing signature of synthetic vs natural soccer fields. Heliyon 5:e02334. doi: 10.1016/j.heliyon.2019.e02334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Mucci N, Gianfranceschi G, Cianfanelli C, Santucci S, Romano Spica V, Valeriani F. 2020. Can air microbiota be a novel marker for public health? A sampling model and preliminary data from different environments. Aerobiologia 36:71–75. doi: 10.1007/s10453-019-09581-3. [DOI] [Google Scholar]
- 45.Pasquarella C, Colucci ME, Bizzarro A, Veronesi L, Affanni P, Meschi T, Brianti E, Vitali P, Albertini R. 2020. Detection of SARS-CoV-2 on hospital surfaces. Acta Biomed 91:76–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Di Maria F, Beccaloni E, Bonadonna L, Cini C, Confalonieri E, La Rosa G, Milana MR, Testai E, Scaini F. 2020. Minimization of spreading of SARS-CoV-2 via household waste produced by subjects affected by COVID-19 or in quarantine. Sci Total Environ 743:140803. doi: 10.1016/j.scitotenv.2020.140803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Veronesi L, Colucci ME, Pasquarella C, Caruso L, Ibrahim MMM, Zoni R, Pergreffi M, Arcuri C, Seidenari C, Viani I, Capobianco E, Mezzetta S, Affanni P. 2020. Virological surveillance of SARS-CoV-2 in an Italian northern area: comparison of Real Time RT PCR cycle threshold (Ct) values in three epidemic periods. Acta Biomed 91:19–21. doi: 10.23750/abm.v91i9-S.10138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Segre JA. 2013. What does it take to satisfy Koch’s postulates two centuries later? Microbial genomics and Propionibacteria acnes. J Invest Dermatol 133:2141–2142. doi: 10.1038/jid.2013.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Aboubakr HA, Sharafeldin TA, Goya SM. 2020. Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review. Transbound Emerg Dis doi: 10.1111/tbed.13707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Morawska L, Tang JW, Bahnfleth W, Bluyssen PM, Boerstra A, Buonanno G, Cao J, Dancer S, Floto A, Franchimon F, Haworth C, Hogeling J, Isaxon C, Jimenez JL, Kurnitski J, Li Y, Loomans M, Marks G, Marr LC, Mazzarella L, Melikov AK, Miller S, Milton DK, Nazaroff W, Nielsen PV, Noakes C, Peccia J, Querol X, Sekhar C, Seppänen O, Tanabe SI, Tellier R, Tham KW, Wargocki P, Wierzbicka A, Yao M. 2020. How can airborne transmission of COVID-19 indoors be minimised? Environ Int 142:105832. doi: 10.1016/j.envint.2020.105832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Schuit M, Ratnesar-Shumate S, Yolitz J, Williams G, Weaver W, Green B, Miller D, Krause M, Beck K, Wood S, Holland B, Bohannon J, Freeburger D, Hooper I, Biryukov J, Altamura LA, Wahl V, Hevey M, Dabisch P. 2020. Airborne SARS-CoV-2 is rapidly inactivated by simulated sunlight. J Infect Dis 222:564–571. doi: 10.1093/infdis/jiaa334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Ratnesar-Shumate S, Williams G, Green B, Krause M, Holland B, Wood S, Bohannon J, Boydston J, Freeburger D, Hooper I, Beck K, Yeager J, Altamura LA, Biryukov J, Yolitz J, Schuit M, Wahl V, Hevey M, Dabisch P. 2020. Simulated sunlight rapidly inactivates SARS-COV-2 on surfaces. J Infect Dis 222:214–222. doi: 10.1093/infdis/jiaa274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Biryukov J, Boydston JA, Dunning RA, Yeager JJ, Wood S, Reese AL, Ferris Q, Miller D, Weaver W, Zeitouni NE, Phillips A, Freeburger D, Hooper I, Ratnesar-Shumate S, Yolitz J, Krause M, Williams G, Dawson DG, Herzog A, Dabisch P, Wahl V, Hevey MC, Altamura LA. 2020. Increasing temperature and relative humidity accelerates inactivation of SARS-CoV-2 on surfaces. mSphere 5:e00441-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Lee YM, Kim YJ, Kim DY, Park KH, Lee MS. 2020. Monitoring environmental contamination caused by SARS-CoV-2 in a healthcare facility by using adenosine triphosphate testing. Am J Infect Control 48:1280–1281. doi: 10.1016/j.ajic.2020.06.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Drosten C. 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 25(3):2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Petersen E, Koopmans M, Go U, Hamer DH, Petrosillo N, Castelli F, Storgaard M, Al Khalili S, Simonsen L. 2020. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis doi: 10.1016/S1473-3099(20)30484-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Centers for Disease Control and Prevention. 2020. CDC 2019-novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel services. Centers for Disease Control and Prevention, Atlanta, GA. https://www.fda.gov/media/134922/download.
- 58.Farfour E, Lesprit P, Visseaux B, Pascreau T, Jolly E, Houhou N, Mazaux L, Asso-Bonnet M, Vasse M, SARS-CoV-2 Foch Hospital study group. 2020. The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis? Eur J Clin Microbiol Infect Dis 39:1997–2000. doi: 10.1007/s10096-020-03930-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Eishi Y, Suga M, Ishige I, Kobayashi D, Yamada T, Takemura T, Takizawa T, Koike M, Kudoh S, Costabel U, Guzman J, Rizzato G, Gambacorta M, du Bois R, Nicholson AG, Sharma OP, Ando M. 2002. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40:198–204. doi: 10.1128/JCM.40.1.198-204.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Chung Y, Kim TS, Min YG, Hong YJ, Park JS, Hwang SM, Song K-H, Kim ES, Park KU, Kim HB, Song J, Kim E-C. 2016. Usefulness of multiplex real-time PCR for simultaneous pathogen detection and resistance profiling of staphylococcal bacteremia. BioMed Res Int 2016:6913860. doi: 10.1155/2016/6913860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Byrd AL, Belkaid Y, Segre JA. 2018. The human skin microbiome. Nat Rev Microbiol 16:143–155. doi: 10.1038/nrmicro.2017.157. [DOI] [PubMed] [Google Scholar]
- 62.Nadkarni MA, Martin FE, Jacques NA, Hunter N. 2002. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148:257–266. doi: 10.1099/00221287-148-1-257. [DOI] [PubMed] [Google Scholar]
- 63.Kittelmann S, Seedorf H, Walters WA, Clemente JC, Knight R, Gordon JI, Janssen PH. 2013. Simultaneous amplicon sequencing to explore co-occurrence patterns of bacterial, archaeal and eukaryotic microorganisms in rumen microbial communities. PLoS One 8:e47879. doi: 10.1371/journal.pone.0047879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Kong Y. 2011. Btrim: a fast, lightweight adapter and quality trimming program for next-generation sequencing technologies. Genomics 98:152–153. doi: 10.1016/j.ygeno.2011.05.009. [DOI] [PubMed] [Google Scholar]
- 65.Wang Q, Garrity GM, Tiedje JM, Cole JR. 2007. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73:5261–5267. doi: 10.1128/AEM.00062-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Colwell RK, Chao A, Gotelli NJ, Lin S-Y, Mao CX, Chazdon RL, Longino JT. 2012. Models and estimators linking individual-based and sample-based rarefaction, extrapolation, and comparison of assemblages. J Plant Ecol 5:3–21. doi: 10.1093/jpe/rtr044. [DOI] [Google Scholar]
- 67.Magurran AE. 2016. Measuring biological diversity. Wiley-Blackwell, Oxford, United Kingdom. [Google Scholar]
- 68.Arndt D, Xia J, Liu Y, Zhou Y, Guo AC, Cruz JA, Sinelnikov I, Budwill K, Nesbø CL, Wishart DS. 2012. METAGENassist: a comprehensive web server for comparative metagenomics. Nucleic Acids Res 40:W88–W95. doi: 10.1093/nar/gks497. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The raw sequencing data were deposited in the NCBI Sequence Read Archive under accession number PRJNA685983. The analyses were carried out using an online Galaxy server available at http://huttenhower.sph.harvard.edu/galaxy.